company background image
6037

Shanghai Hile Bio-Technology SHSE:603718 Stock Report

Last Price

CN¥10.85

Market Cap

CN¥7.0b

7D

-1.5%

1Y

-18.4%

Updated

10 Aug, 2022

Data

Company Financials
603718 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

603718 Stock Overview

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.

Shanghai Hile Bio-Technology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Hile Bio-Technology
Historical stock prices
Current Share PriceCN¥10.85
52 Week HighCN¥16.83
52 Week LowCN¥9.73
Beta0.76
1 Month Change-2.69%
3 Month Change-5.65%
1 Year Change-18.42%
3 Year Change-12.15%
5 Year Change-19.99%
Change since IPO154.38%

Recent News & Updates

Shareholder Returns

603718CN PharmaceuticalsCN Market
7D-1.5%1.6%2.3%
1Y-18.4%-17.5%-11.7%

Return vs Industry: 603718 underperformed the CN Pharmaceuticals industry which returned -16.7% over the past year.

Return vs Market: 603718 underperformed the CN Market which returned -11.4% over the past year.

Price Volatility

Is 603718's price volatile compared to industry and market?
603718 volatility
603718 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.0%
10% most volatile stocks in CN Market9.2%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 603718 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 603718's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1981542Bin Suhttps://www.hile-bio.com

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of porcine parvovirus disease; pathogenic porcine reproductive and respiratory syndrome live vaccines; transmissible gastroenteritis, porcine epidemic diarrhea, and porcine rotavirus triple live vaccines; porcine reproductive and respiratory syndrome live vaccines; swine transmissible gastroenteritis and swine epidemic diarrhea combined inactivated vaccines; porcine circovirus type 2 inactivated vaccines; and swine Japanese encephalitis live vaccines. It also provides chicken infectious bursal disease live vaccines; inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease and avian infectious bronchitis combined live vaccines; newcastle disease low virulent live vaccines; Marek's disease turkey herpes virus live vaccines; and fowlpox live vaccines.

Shanghai Hile Bio-Technology Co., Ltd. Fundamentals Summary

How do Shanghai Hile Bio-Technology's earnings and revenue compare to its market cap?
603718 fundamental statistics
Market CapCN¥6.99b
Earnings (TTM)CN¥51.01m
Revenue (TTM)CN¥331.30m

137.0x

P/E Ratio

21.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
603718 income statement (TTM)
RevenueCN¥331.30m
Cost of RevenueCN¥149.39m
Gross ProfitCN¥181.91m
Other ExpensesCN¥130.90m
EarningsCN¥51.01m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.079
Gross Margin54.91%
Net Profit Margin15.40%
Debt/Equity Ratio56.3%

How did 603718 perform over the long term?

See historical performance and comparison